Results
BofA Lowers Definitive Healthcare Target to $3.50
BofA cut Definitive Healthcare's price target to $3.50 from $4.00, citing weaker 2026 guidance and lower EBITDA multiple.
Q4 revenue rose 3% and adjusted EBITDA 9% above consensus, but total customers
